Trident Texofab Corporate Filings & Announcements

Latest corporate announcements and filings from Trident Texofab on BSE

Search Inside the pdf :

Trident Texofab Ltd.

30 Dec 2025

252.95

0.64%

SAST

Trident Texofab Ltd - 540726 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from January 01, 2026 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter and Nine months ended December 31, 2025

pdf

Trident Texofab Ltd.

15 Nov 2025

252.95

0.64%

Company Update

Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on November 15, 2025 regarding extract of the Un-Audited Standalone Financial Results for the quarter and Half year ended September 30, 2025

pdf

Trident Texofab Ltd.

15 Nov 2025

252.95

0.64%

Investor Presentation

Trident Texofab Ltd - 540726 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Earnings Presentation for the quarter and Half year ended September 30, 2025

pdf

Trident Texofab Ltd.

13 Nov 2025

252.95

0.64%

Result

Trident Texofab Ltd - 540726 - Result-Financial Result For The Quarter Ended 30.09.2025

BSE India

The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone Financial Results for the quarter and half year ended on September 30, 2025 along with Limited Review Report on said results issued by the Statutory Auditor of the Company.

pdf

Trident Texofab Ltd.

13 Nov 2025

252.95

0.64%

Board Meeting

Trident Texofab Ltd - 540726 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

pdf

Trident Texofab Ltd.

05 Nov 2025, 06:06PM

252.95

0.64%

Board Meeting

Trident Texofab Ltd - 540726 - Board Meeting Intimation for Considering Un-Audited Financial Result For Quarter …

BSE India

Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-Audited Financial result for Quarter and half year ended September 30, 2025

pdf

Trident Texofab Ltd.

03 Oct 2025

252.95

0.64%

Company Update

Trident Texofab Ltd - 540726 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from KFin Technologies Limited- Company''s Registrar and Share Transfer Agent for the quarter ended September 30, 2025.

pdf

Trident Texofab Ltd.

29 Sep 2025

252.95

0.64%

SAST

Trident Texofab Ltd - 540726 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, we wish to inform you that the Trading Window for dealing in securities of the Company shall remain closed with effect from October 01, 2025 and shall be opened 48 (Forty-Eight) hours after the conclusion of the Meeting of the Board of Directors to be held for the purpose of declaration of Un-Audited Standalone Financial Results for the Quarter and half year ended September 30, 2025.

pdf

Trident Texofab Ltd.

26 Sep 2025

252.95

0.64%

AGM

Trident Texofab Ltd - 540726 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting and e-voting during AGM of the Company held on Thursday, September 25, 2025

pdf

Trident Texofab Ltd.

25 Sep 2025

252.95

0.64%

AGM

Trident Texofab Ltd - 540726 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Proceeding and Outcome of 17th Annual General Meeting (AGM) of the members of the Company.

pdf

Is Trident Texofab Ltd. worth buying?

42 Votes:

Buy 64.29%

Sell 19.05%

Hold 16.67%